Annual Current Ratio
4.17
-0.04-0.95%
31 December 2023
Summary:
Monopar Therapeutics annual current ratio is currently 4.17, with the most recent change of -0.04 (-0.95%) on 31 December 2023. During the last 3 years, it has fallen by -10.11 (-70.80%). MNPR annual current ratio is now -87.16% below its all-time high of 32.48, reached on 31 December 2016.MNPR Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
5.41
-1.18-17.91%
30 September 2024
Summary:
Monopar Therapeutics quarterly current ratio is currently 5.41, with the most recent change of -1.18 (-17.91%) on 30 September 2024. Over the past year, it has increased by +1.09 (+25.23%). MNPR quarterly current ratio is now -83.11% below its all-time high of 32.04, reached on 31 March 2021.MNPR Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | +25.2% |
| 3 y3 years | -70.8% | -70.1% |
| 5 y5 years | -77.0% | -48.8% |
MNPR Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.8% | at low | -70.1% | +32.6% |
| 5 y | 5 years | -77.2% | at low | -83.1% | +32.6% |
| alltime | all time | -87.2% | at low | -83.1% | +32.6% |
Monopar Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 5.41(-17.9%) |
| June 2024 | - | 6.59(+6.1%) |
| Mar 2024 | - | 6.21(+48.9%) |
| Dec 2023 | 4.17(-1.0%) | 4.17(-3.5%) |
| Sept 2023 | - | 4.32(+4.9%) |
| June 2023 | - | 4.12(+1.0%) |
| Mar 2023 | - | 4.08(-3.1%) |
| Dec 2022 | 4.21(-67.6%) | 4.21(-43.9%) |
| Sept 2022 | - | 7.51(-1.3%) |
| June 2022 | - | 7.61(-54.6%) |
| Mar 2022 | - | 16.77(+29.2%) |
| Dec 2021 | 12.98 | 12.98(-28.3%) |
| Sept 2021 | - | 18.11(-18.1%) |
| June 2021 | - | 22.10(-31.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 32.04(+124.4%) |
| Dec 2020 | 14.28(-21.8%) | 14.28(-51.9%) |
| Sept 2020 | - | 29.66(+33.5%) |
| June 2020 | - | 22.21(-22.5%) |
| Mar 2020 | - | 28.67(+56.9%) |
| Dec 2019 | 18.27(+0.7%) | 18.27(+73.0%) |
| Sept 2019 | - | 10.56(-11.6%) |
| June 2019 | - | 11.95(+9.1%) |
| Mar 2019 | - | 10.95(-39.7%) |
| Dec 2018 | 18.15(-38.0%) | 18.15(-28.2%) |
| Sept 2018 | - | 25.29(+6.8%) |
| June 2018 | - | 23.67(-17.6%) |
| Mar 2018 | - | 28.73(-1.9%) |
| Dec 2017 | 29.28(-9.9%) | 29.28 |
| Dec 2016 | 32.48 | - |
FAQ
- What is Monopar Therapeutics annual current ratio?
- What is the all time high annual current ratio for Monopar Therapeutics?
- What is Monopar Therapeutics annual current ratio year-on-year change?
- What is Monopar Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly current ratio year-on-year change?
What is Monopar Therapeutics annual current ratio?
The current annual current ratio of MNPR is 4.17
What is the all time high annual current ratio for Monopar Therapeutics?
Monopar Therapeutics all-time high annual current ratio is 32.48
What is Monopar Therapeutics annual current ratio year-on-year change?
Over the past year, MNPR annual current ratio has changed by -0.04 (-0.95%)
What is Monopar Therapeutics quarterly current ratio?
The current quarterly current ratio of MNPR is 5.41
What is the all time high quarterly current ratio for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly current ratio is 32.04
What is Monopar Therapeutics quarterly current ratio year-on-year change?
Over the past year, MNPR quarterly current ratio has changed by +1.09 (+25.23%)